Artificial Intelligence-assisted Insulin System in Type 2 Diabetes in General Wards
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 144 participants.
Also called NCT06319300
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 144 participants
- Registry
-
NCT06319300
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT06319300. Randomized; single masking; primary purpose treatment. Start 2024-04-19 (actual); primary completion 2025-09-20 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Artificial Intelligence-assisted Insulin System in Type 2 Diabetes in General Wards
- Condition
- Diabetes Type 2
- Intervention (Device)
- AI-assisted insulin dose adjustment model
- Intervention (Other)
- doctor's insulin dose adjustment
- Lead sponsor
- Shanghai Zhongshan Hospital
- Collaborator
- Fudan University
Record details
- Record id
cardio:ct-nct06319300- Content hash
e1b4f7d63049864420877f428b6fcfa318b0d40c52344b9d2e8d3f60bed16efe